MyFinsight

Income Statement
Edwards Lifesciences Corp (EW)
source: myfinsight.com
Download image
Europe Segment$378.2M Japan Segment$95.3M Rest Of World Segment$169M United States Segment$889.7M Net sales$1,532.2M (10.56%↑ Y/Y)Gross profit$1,187.8M (7.92%↑ Y/Y)Other operatingincome$21.3M Cost of sales$344.4M (20.72%↑ Y/Y)Interest income, net$37.4M Operating income, net$411.2M (11.41%↑ Y/Y)Certain litigationexpenses$15.5M (91.36%↑ Y/Y)Research and developmentexpenses$276.2M (1.32%↑ Y/Y)Separation costs (note 3)$4.2M Selling, general, andadministrative expenses$502M (11.36%↑ Y/Y)Income from continuingoperations before...$400.2M (3.52%↑ Y/Y)Loss on impairment$47.1M Other non-operatingexpense (income), net-$1.3M (-165.00%↓ Y/Y)Net income fromcontinuing operations$335.9M (-8.32%↓ Y/Y)Provision for income taxes$64.3M (218.32%↑ Y/Y)Net lossattributable to...-$1.7M (-30.77%↓ Y/Y)Net income$331.5M (-9.18%↓ Y/Y)(loss) income fromdiscontinued operations, net...-$4.4M (-214.29%↓ Y/Y)Net incomeattributable to edwards...$333.2M (-9.04%↓ Y/Y)